NEWS
Last year we released a blog post on 5 recent Payer trends in Diagnostics. What are the latest developments? Check out this short summary:
Growing appetite for diagnostics health technology assessment in Europe
Joint (regulator-payer) evidence reviews and scientific advice to MedTech manufacturers gain further momentum in the US
Payers start to embrace Digital Health
In Vitro Diagnostics is going through exciting times. Pricing, reimbursement, policy topics are getting more and more relevant in the industry.
We have summarized 5 recent Payer trends, shaping the industry.
Do you want to have the collection of the supporting trend examples, please drop us a line.
Do you see other relevant trends that we might have missed, please comment.
